Psychedelics like MDMA, LSD, and psilocybin being researched for treating conditions like depression, addiction, and anxiety in renewed interest.
FDA panel review raised concerns over data reliability, safety risks including heart problems, injury, and drug abuse with MDMA use for PTSD treatment.
Study challenges arise due to the intense psychological effects of MDMA; patients can often guess if they received the drug or a placebo, impacting objectivity in research.
Collection
[
|
...
]